0 Items - $0.00
Categories
A to Z

Alternative structural projections:

8-MA-cAMP

8- Methylaminoadenosine- 3', 5' cyclic monophosphate (8-MA-cAMP), sodium salt
Site-selective PKA agonist
Cat. No.: M 001
    
CAS No.: [33823-18-6]
Shipping: ambient
Product Name Price (net) Qty
Cat. No.: M 001-10
Unit: 10 µmol / ~3.8 mg
$90.00
For other salt forms or metabolites please inquire. Site-selective cyclic AMP analogue with similar affinity to site B of both protein kinase A type I and II. Priming analogue which acts synergistically together with analogues showing site A preference. Together with e.g. 8-PIP-cAMP (Cat. No. P 002) selective stimulation of type I can be achieved. Detailed technical information and selected references available. Reference: Skalhegg et al., J. Biol. Chem., 267, 15707 - 15714 (1992).
Cat. No. M 001
CAS number [33823-18-6]
Purity > 98% HPLC
Salt form Sodium
Storage temperature -20°C / -4°F
Molecular formula C₁₁H₁₄N₆O₆P · Na
Molecular weight [g/mol] 380,2
Modifications 8-cAMP
Target PKA (cAK) Activator
Lipophilicity 1.10
Absorption max [nm] 273
Molar extinction coefficient ε [L·mol⁻¹·cm⁻¹] 15000
  • 1. Gausdal G., Wergeland A., Skavland J., Nguyen E., Pendino F., Rouhee N., McCormack E., Herfindal L., Kleppe R., Havemann U., Schwede F., Bruseud O., Gjertsen B. T., Lanotte M., Segal-Bendirdjian E.Doskeland S. O., Cell Death Dis., 4, 0 - 0 (2013), "Cyclic AMP Can Promote APL Progression and Protect Myeloid Leukemia Cells Against Anthracycline-Induced Apoptosis"
  • 2. Jäger R., Russwurm C., Schwede F., Genieser H.-G., Koesling D.Russwurm M., J. Biol. Chem., 287, 1210 - 1219 (2012), "Activation of PDE10 and PDE11 Phosphodiesterases"
  • 3. Dao K. K., Teigen K., Kopperud R. K., Hodneland E., Schwede F., Christensen A. E., Martinez A.Doeskeland S. O., J. Biol. Chem., 281, 21500 - 21511 (2006), "Epac1 and cAMP-dependent Protein Kinase Holoenzyme Have Similar cAMP Affinity, but Their cAMP Domains Have Distinct Structural Features and Cyclic Nucleotide Recognition"
  • 4. Rehmann H., Schwede F., Doeskeland S. O., Wittinghofer A.Bos J. L., J. Biol. Chem., 278, 38548 - 38556 (2003), "Ligand-mediated Activation of the cAMP-responsive Guanine Nucleotide Exchange Factor Epac"
  • 5. Christensen A. E.Doeskeland S. O., Handbook of Cell Signaling Academic Press/Elsevier Science San Diego CA, 2, 549 - 554 (2003), "Cyclic Nucleotide Analogs as Tools to Investigate Cyclic Nucleotide Signaling"
  • 6. Schwede F., Christensen A., Liauw S., Hippe T., Kopperud R. K., Jastorff B.Doeskeland S. O., Biochemistry, 39, 8803 - 8812 (2000), "8-Substituted cAMP Analogues Reveal Marked Differences in Adaptability, Hydrogen Bonding, and Charge Accomodation between Homologous Binding Sites (AI/AII and BI/BII) in cAMP Kinase I and II"
  • 7. Christensen A., Dao K. K., Doeskeland S. O., Schwede F., Jastorff B., Genieser H.-G., de Rooij J., Bos J. L., Rehmann H., Kraemer A.Wittinghofer A., 12th Protein Kinase Symp. NO/cGMP and Protein Kinase Signaling Bad Brückenau/Germany, 0, 0 - 0 (2000), "8-Modified cAMP Analogs give Insight into the Geometries of the cAMP Binding Sites of RI, RII and EPAC-1"
  • 8. Koizumi M.Breaker R. R., Biochemistry, 39, 8983 - 8992 (2000), "Molecular Recognition of cAMP by an RNA Aptamer"
  • 9. Muhonen W. W.Shabb J. B., Protein Sci., 9, 2446 - 2456 (2000), "Resonant Mirror Biosensor Analysis of Type I(Alpha) cAMP-dependent Protein Kinase B Domain-Cyclic Nucleotide Interactions"
  • 10. Cho-Chung Y. S., Jastorff B.Genieser H.-G., USA patent 5916, 843, 0 - 0 (1998), "Cyclic AMP Analogues, Individually and in Pairs, to Inhibit Neoplastic Cell Growth"
  • 11. Cho-Chung Y. S.Robins R. K., United States Patent 5752 of August 11, 792, 0 - 0 (1998), "8-Chloro cAMP and Related cAMP Compounds as Antineoplastic Agents"
  • 12. Maronde E., Middendorff R., Telgmann R., Müller D., Hemmings B., Tasken K.Olcese J., J. Neurochem., 68, 770 - 777 (1997), "Melatonin Synthesis in the Bovine Pineal Gland is Regulated by Type II Cyclic AMP-Dependent Protein Kinase"
  • 13. Torgersen K. M., Vaage J. T., Levy F. O., Hansson V., Rolstad B.Tasken K., J. Biol. Chem., 272, 5495 - 5500 (1997), "Selective Activation of cAMP-Dependent Protein Kinase Type I Inhibits Rat Natural Killer Cell Cytotoxicity"
  • 14. Krass J. D., Jastorff B.Genieser H.-G., Anal. Chem., 69, 2575 - 2581 (1997), "Determination of Lipophilicity by Gradient Elution High-Performance Liquid Chromatography"
  • 15. Kapphahn M. A.Shabb J. B., Arch. Biochem. Biophys., 348, 347 - 356 (1997), "Contribution of the Carboxyl-Terminal Region of the cAMP-dependent Protein Kinase Type I(Alpha) Regulatory Subunit to Cyclic Nucleotide Interactions"
  • 16. Huq I., Dostmann W. R. G.Oegreid D., Biochem. J., 316, 337 - 343 (1996), "Isoleucine 368 is Involved in Low-Affinity Binding of N6-Modified cAMP Analogues to Site B of the Regulatory Subunit of cAMP-Dependent Protein Kinase I"
  • 17. Zorn M., Fladmark K. E., Oegreid D., Jastorff B., Doeskeland S. O.Dostmann W. R. G., FEBS Lett., 362, 291 - 294 (1995), "Ala 335 is Essential for High-affinity cAMP-binding of Both Sites A and B of cAMP-dependent Protein Kinase Type I"
  • 18. Muresan S., Bologa C., Mracec M., Chiriac A., Jastorff B., Simon Z.Naray-Szabo G., J. Mol. Struct., 342, 161 - 171 (1995), "Comparative QSAR Study with Electronic and Steric Parameters for cAMP Derivatives with Large Substituents in Positions 2, 6 and 8"
  • 19. Scott S.-P.Tanaka J. C., Biochemistry, 34, 2338 - 2347 (1995), "Molecular Interactions of 3',5'-Cyclic Purine Analogues with the Binding Site of Retinal Rod Ion Channels"
  • 20. Vintermyr O. K., Böe R., Brustugun O. T., Maronde E., Aakvaag A.Doeskeland S. O., Endocrinology, 136, 2513 - 2520 (1995), "Cyclic Adenosine Monophosphate (cAMP) Analogs 8-Cl- and 8-NH(2)-cAMP Induce Cell Death Independently of cAMP Kinase-Mediated Inhibition of the G(1)/S Transition in Mammary Carcinoma Cells (MCF-7)"
  • 21. Muresan S., Bologa C., Chiriac A., Jastorff B., Kurunczi L.Simon Z., Quant. Struct.-Act. Relat., 13, 242 - 248 (1994), "Comparative Structure-Affinity Relations by MTD for Binding of Cycloadenosine Monophosphate Derivatives to Protein Kinase Receptors"
  • 22. Müller G.Bandlow W., Arch. Biochem. Biophys., 308, 504 - 514 (1994), "Lipolytic Membrane Release of Two Phosphatidylinositol-Anchored cAMP Receptor Proteins in Yeast Alters Their Ligand-Binding Parameters"
  • 23. Skalhegg B. S., Landmark B. F., Doeskeland S. O., Hansson V., Lea T.Jahnsen T., J. Biol. Chem., 267, 15707 - 15714 (1992), "Cyclic AMP-dependent Protein Kinase Type I Mediates the Inhibitory Effects of 3', 5'-Cyclic Adenosine Monophosphate on Cell Replication in Human T Lymphocytes"
  • 24. Doeskeland S. O., Boe R., Bruland T., Vintermyr O. K., Jastorff B.Lanotte M., Method. Surveys Biochem. & Anal., E. Reid et al. (eds.). Royal Society Chem. Cambridge UK , Redwood Press Ltd., 21, 103 - 114 (1991), "Criteria Used to Judge That a Cellular Response is Mediated by Cyclic AMP"
  • 25. Lanotte M., Riviere J. B., Hermouet S., Houge G., Vintermyr O. K., Gjertsen B. T.Doeskeland S. O., J. Cell. Physiol., 146, 73 - 80 (1991), "Programmed Cell Death (Apoptosis) Is Induced Rapidly and With Positive Cooperativity by Activation of Cyclic Adenosine Monophosphate-Kinase I in a Myeloid Leukemia Cell Line"
  • 26. Oegreid D., Ekanger R., Suva R. H., Miller J. P.Doeskeland S. O., Eur. J. Biochem., 181, 19 - 31 (1989), "Comparison of the Two Classes of Binding Sites ( A and B ) of Type I and Type II Cyclic AMP-dependent Protein Kinases Using Cyclic Nucleotide Analogs"
  • 27. Cho-Chung Y. S., Clair T., Tagliaferri P., Ally S., Katsaros D., Tortora G., Neckers L. M., Avery T. L., Crabtree G. W.Robins R. K., Cancer Invest., 7, 161 - 177 (1989), "Site-selective Cyclic AMP Analogs as New Biological Tools in Growth Control, Differentiation, and Proto-oncogene Regulation"
  • 28. Tortora G., Tagliaferri P., Clair T., Colamonici O., Neckers L. M., Robins R. K.Cho-Chung J.-S., Blood, 71, 230 - 233 (1988), "Site-selective Cyclic AMP Analogs at Micromolar Concentrations Induce Growth Arrest and Differentiation of Acute Promyelocytic, Chronic Myelocytic, and Acute Lymphocytic Human Leukemia Cell Lines"
  • 29. Tagliaferri P., Katsaros D., Clair T., Ally S., Tortora G., Neckers L. M., Rubalcava B., Parandoosh Z., Chang Y.-A., Revankar G. R., Crabtree G. W., Robins R. K.Cho-Chung Y. S., Cancer Res., 48, 1642 - 1650 (1988), "Synergistic Inhibition of Growth of Breast and Colon Human Cancer Cell Lines by Site-selective Cyclic AMP Analogs"
  • 30. Beebe S. J., Beasley-Leach A.Corbin J. D., Methods Enzymol., 159, 531 - 540 (1988), "cAMP Analogs Used to Study Low-km, Hormone-sensitive Phosphodiesterase"
  • 31. Katsaros D., Tortora G., Tagliaferri P., Clair T., Ally S., Neckers L. M., Robins R. K.Cho-Chung Y. S., FEBS Lett., 223, 97 - 103 (1987), "Site-selective Cyclic AMP Analogs Provide a New Approach in the Control of Cancer Cell Growth"
  • 32. Clair T., Ally S., Tagliaferri P., Robins R. K.Cho-Chung Y. S., FEBS Lett., 224, 377 - 384 (1987), "Site-selective Cyclic AMP Analogs Induce Nuclear Translocation of the RII cAMP Receptor Protein in Ha-MuSV-Transformed NIH/3T3 Cells"
  • 33. Bubis J.Taylor S. S., Biochemistry, 26, 5997 - 6004 (1987), "Limited Proteolysis Alters the Photoaffinity Labeling of Adenosine 3',5'- Monophosphate Dependent Protein Kinase II with 8-Azidoadenosine 3',5'- Monophosphate"
  • 34. Braumann T.Jastorff B., J. Chromatogr., 350, 105 - 118 (1985), "Physicochemical Characterization of Cyclic Nucleotides by Reversed Phase High-Performance Liquid Chromatography. II. Quantitative Determination of Hydrophobicity"
  • 35. Scholübbers H.-G., Van Knippenberg P. H., Baraniak J., Stec W. J., Morr M.Jastorff B., Eur. J. Biochem., 138, 101 - 109 (1984), "Investigations on Stimulation of Lac Transciption in Vivo in Escherichia Coli by cAMP Analogs"
  • 36. Donnelly T. E.Barron B., Biochim. Biophys. Acta, 657, 168 - 178 (1981), "Effects of Divalent Metals on the Specificity of Inhibitors of the Cyclic Nucleotide Phosphodiesterases from Bovine Heart"
  • 37. Miller J. P., Adv. Cyclic Nucl. Res., 14, 335 - 344 (1981), "Cyclic AMP Derivatives as Tools for Mapping Cyclic AMP Binding Sites of Cyclic AMP-dependent Protein Kinases I and II"
  • 38. Sasaki Y., Suzuki N., Sowa T., Nozawa R.Yokota T., Biochemistry, 15, 1408 - 1413 (1976), "Effects of 8-Substituted Adenosine 3',5'-monophosphate Derivatives on High Km Phosphodiesterase Activity"
  • 39. Miller J. P., Beck A. H., Simon L. N.Meyer R. B., J. Biol. Chem., 250, 426 - 431 (1975), "Induction of Hepatic Tyrosine Aminotransferase in Vivo by Derivatives of Cyclic Adenosine 3',5'- Monophosphate"
  • 40. Khwaja T. A., Boswell K. H., Robins R. K.Miller J. P., Biochemistry, 14, 4238 - 4244 (1975), "8-Substituted Derivatives of Adenosine 3', 5'- Cyclic Phosphate Require an Unsubstituted 2'- Hydroxyl Group in the Ribo Configuration for Biological Activity"
  • 41. Siggins G. R.Henriksen S. J., Science, 189, 559 - 560 (1975), "Analogs of Cyclic Adenosine Monophosphate: Correlation of Inhibition of Purkinje Neurons with Protein Kinase Activation"
  • 42. Meyer R. B.Miller J. P., Life Sci., 14, 1019 - 1040 (1974), "Analogs of Cyclic AMP and Cyclic GMP: General Methods of Synthesis and the Relationship of Structure to Enzymatic Activity"
  • 43. Kuo J. F., Miyamoto E.Reyes P. L., Biochem. Pharmacol., 23, 2011 - 2021 (1974), "Activation and Dissociation of Adenosine 3', 5'- Monophosphate-dependent and Guanosine 3', 5'- monophosphate-dependent Protein Kinases by Various Cyclic Nucleotide Analogs"
  • 44. Nelböck M., Michal G.Weimann G., Pure Appl. Chem., 35, 411 - 437 (1973), "Analogues of Cyclic AMP and their Physiological Response"
  • 45. Muneyama K., Bauer R. J., Shuman D. A., Robins R. K.Simon L. N., Biochemistry, 10, 2390 - 2395 (1971), "Chemical Synthesis and Biological Activity of 8-Substituted Adenosine 3',5'- Cyclic Monophosphate Derivatives"
  • 46. Free C. A., Chasin M., Paik V. S.Hess S. M., Biochemistry, 10, 3785 - 3789 (1971), "Steroidogenic and Lipolytic Activities of 8-Substituted Derivatives of Cyclic 3',5'-Adenosine Monophosphate"

Show more